v3.26.1
Condensed Consolidated Statements of Changes in Convertible Preferred Stock, Stockholders’ Equity and Non-Controlling Interest - USD ($)
$ in Thousands
Total
Additional Paid-In Capital
Accumulated Deficit
Non- Controlling Interests
Common Stock Class A
Common Stock Class A
Common Stock
Common Stock Class F
Common Stock
Common Stock Class B
Common Stock Class B
Common Stock
Balance as of beginning of period (in shares) at Dec. 31, 2024 11,865,046                
Balance as of beginning of period at Dec. 31, 2024 $ 25,018                
Balance as of end of period (in shares) at Mar. 31, 2025 11,865,046                
Balance as of end of period at Mar. 31, 2025 $ 25,018                
Common stock, beginning balance (in shares) at Dec. 31, 2024           2,455,894 10,000,000   20,075,183
Beginning balance at Dec. 31, 2024 42,595 $ 200,811 $ (169,846) $ 11,627   $ 0 $ 1   $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of Class B Common Stock (in shares)                 60,596
Issuance of Class B Common Stock 963 963              
Redemption of Class B Common Stock (in shares)                 (202,653)
Redemption of Class B Common Stock (2,174) (2,174)              
Offering costs for Class B Common Stock (21) (21)              
Exercise of Common A RSOs (in shares)           2,500      
Exercise of Common A RSOs 13 13              
Distribution of Member’s Equity of NCI (53)     (53)          
Net income (loss) (4,241)   (4,403) 162          
Common stock, ending balance (in shares) at Mar. 31, 2025           2,458,394 10,000,000   19,933,126
Ending balance at Mar. 31, 2025 $ 37,082 199,592 (174,249) 11,736   $ 0 $ 1   $ 2
Balance as of beginning of period (in shares) at Dec. 31, 2024 11,865,046                
Balance as of beginning of period at Dec. 31, 2024 $ 25,018                
Balance as of end of period (in shares) at Jun. 30, 2025 11,865,046                
Balance as of end of period at Jun. 30, 2025 $ 25,018                
Common stock, beginning balance (in shares) at Dec. 31, 2024           2,455,894 10,000,000   20,075,183
Beginning balance at Dec. 31, 2024 42,595 200,811 (169,846) 11,627   $ 0 $ 1   $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (5,913)                
Common stock, ending balance (in shares) at Jun. 30, 2025           2,458,394 10,000,000   19,949,041
Ending balance at Jun. 30, 2025 $ 36,984 201,166 (176,086) 11,901   $ 0 $ 1   $ 2
Balance as of beginning of period (in shares) at Mar. 31, 2025 11,865,046                
Balance as of beginning of period at Mar. 31, 2025 $ 25,018                
Balance as of end of period (in shares) at Jun. 30, 2025 11,865,046                
Balance as of end of period at Jun. 30, 2025 $ 25,018                
Common stock, beginning balance (in shares) at Mar. 31, 2025           2,458,394 10,000,000   19,933,126
Beginning balance at Mar. 31, 2025 37,082 199,592 (174,249) 11,736   $ 0 $ 1   $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of Class B Common Stock (in shares)                 226,070
Issuance of Class B Common Stock 3,595 3,595              
Redemption of Class B Common Stock (in shares)                 (210,155)
Redemption of Class B Common Stock (2,020) (2,020)              
Offering costs for Class B Common Stock (1) (1)              
Net income (loss) (1,672)   (1,837) 165          
Common stock, ending balance (in shares) at Jun. 30, 2025           2,458,394 10,000,000   19,949,041
Ending balance at Jun. 30, 2025 $ 36,984 201,166 (176,086) 11,901   $ 0 $ 1   $ 2
Balance as of beginning of period (in shares) at Dec. 31, 2025 11,865,046                
Balance as of beginning of period at Dec. 31, 2025 [1] $ 25,018                
Balance as of end of period (in shares) at Mar. 31, 2026 11,865,046                
Balance as of end of period at Mar. 31, 2026 $ 25,018                
Common stock, beginning balance (in shares) at Dec. 31, 2025         2,458,394 2,458,394 10,000,000 19,826,469 19,826,469
Beginning balance at Dec. 31, 2025 30,548 [1] 200,586 (182,298) 12,257   $ 0 $ 1   $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Reclassification of Accumulated Deficit to NCI 0   (1,332) 1,332          
Issuance of Class B Common Stock (in shares)                 236,326
Issuance of Class B Common Stock 3,758 3,758              
Redemption of Class B Common Stock (in shares)                 (6,206)
Redemption of Class B Common Stock (73) (73)              
Offering costs for Class B Common Stock (23) (23)              
Distribution of Member’s Equity of NCI (2,450)     (2,450)          
Net income (loss) (3,955)   (4,084) 129          
Common stock, ending balance (in shares) at Mar. 31, 2026           2,458,394 10,000,000   20,056,589
Ending balance at Mar. 31, 2026 $ 27,805 204,248 (187,714) 11,268   $ 0 $ 1   $ 2
Balance as of beginning of period (in shares) at Dec. 31, 2025 11,865,046                
Balance as of beginning of period at Dec. 31, 2025 [1] $ 25,018                
Balance as of end of period (in shares) at Jun. 30, 2026 11,865,046                
Balance as of end of period at Jun. 30, 2026 $ 25,018                
Common stock, beginning balance (in shares) at Dec. 31, 2025         2,458,394 2,458,394 10,000,000 19,826,469 19,826,469
Beginning balance at Dec. 31, 2025 30,548 [1] 200,586 (182,298) 12,257   $ 0 $ 1   $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Reclassification of Accumulated Deficit to NCI     (1,300) 1,300          
Net income (loss) (7,087)                
Common stock, ending balance (in shares) at Jun. 30, 2026         2,458,394 2,458,394 10,000,000 20,142,285 20,142,285
Ending balance at Jun. 30, 2026 $ 14,616 205,625 (191,092) 80   $ 0 $ 1   $ 2
Balance as of beginning of period (in shares) at Mar. 31, 2026 11,865,046                
Balance as of beginning of period at Mar. 31, 2026 $ 25,018                
Balance as of end of period (in shares) at Jun. 30, 2026 11,865,046                
Balance as of end of period at Jun. 30, 2026 $ 25,018                
Common stock, beginning balance (in shares) at Mar. 31, 2026           2,458,394 10,000,000   20,056,589
Beginning balance at Mar. 31, 2026 27,805 204,248 (187,714) 11,268   $ 0 $ 1   $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of Class B Common Stock (in shares)                 90,140
Issuance of Class B Common Stock 1,433 1,433              
Redemption of Class B Common Stock (in shares)                 (4,444)
Redemption of Class B Common Stock (50) (50)              
Offering costs for Class B Common Stock (6) (6)              
Distribution of Member’s Equity of NCI (11,434)     (11,434)          
Net income (loss) (3,132)   (3,378) 246          
Common stock, ending balance (in shares) at Jun. 30, 2026         2,458,394 2,458,394 10,000,000 20,142,285 20,142,285
Ending balance at Jun. 30, 2026 $ 14,616 $ 205,625 $ (191,092) $ 80   $ 0 $ 1   $ 2
[1] Derived from audited financials